Blocking macropinocytosis reshapes the tumor microenvironment to be less fibrous and to allow more access to immune cells, according to a preclinical study of pancreatic tumors conducted by scientists at Sanford Burnham Prebys, an NCI-designated Cancer Center.
The Stephenson Global Pancreatic Cancer Research Institute and its partner, City of Hope, announced the six inaugural recipients of the Stephenson Scholar Grants, awarding $5.25 million to support high-impact research aimed at transforming the understanding, early detection, and treatment of pancreatic cancer (The Cancer Letter, Sept. 17, 2024).
